Varenicline (Chantix) Dosing for Smoking Cessation
The recommended varenicline dosing schedule is 0.5 mg once daily for days 1-3, then 0.5 mg twice daily for days 4-7, followed by 1 mg twice daily from day 8 through week 12, with treatment initiated 1-2 weeks before the target quit date. 1
Standard Dosing Regimen
The FDA-approved dosing schedule follows a titration approach to minimize side effects, particularly nausea:
- Days 1-3: 0.5 mg orally once daily
- Days 4-7: 0.5 mg orally twice daily
- Day 8 through week 12: 1 mg orally twice daily (target dose)
Take varenicline after eating with a full glass of water to reduce gastrointestinal side effects 1. Begin dosing 1-2 weeks before the planned quit date 2.
Treatment Duration
The initial treatment course is 12 weeks 2, 1. For patients who successfully quit smoking at 12 weeks, an additional 12-week course (total 24 weeks) is recommended to further increase long-term abstinence rates 2, 1. This extended treatment approach has been validated in clinical trials showing improved maintenance of abstinence 3.
Alternative Dosing Approaches
Gradual Quit Approach
For patients unable or unwilling to quit abruptly, varenicline can be started with a gradual reduction strategy:
- Begin standard dosing
- Reduce smoking by 50% within first 4 weeks
- Reduce by another 50% in next 4 weeks
- Achieve complete abstinence by week 12
- Continue treatment for additional 12 weeks (total 24 weeks) 1
Flexible Dosing
If patients cannot tolerate the full 1 mg twice daily dose due to side effects (particularly nausea), consider dose reduction to 0.5 mg twice daily or even 0.5 mg once daily 4. Studies show that lower doses (averaging 1.3 mg/day) can still achieve abstinence rates exceeding 40% at 12 weeks while reducing dose-dependent adverse effects 4.
Special Populations
Renal Impairment
- Mild to moderate renal impairment: No dose adjustment needed
- Severe renal impairment (CrCl <30 mL/min): Start with 0.5 mg once daily, may titrate to maximum 0.5 mg twice daily
- End-stage renal disease on hemodialysis: Maximum 0.5 mg once daily 1
Elderly Patients
No dose adjustment required for age alone, but monitor renal function as elderly patients are more likely to have decreased renal function 1.
Hepatic Impairment
No dose adjustment necessary 1.
Critical Safety Considerations
Monitor all patients for neuropsychiatric symptoms including depression, suicidal ideation, agitation, and behavioral changes, though large-scale trials (EAGLES study with 8,144 participants) found no significant increase in neuropsychiatric adverse events compared to placebo or nicotine replacement therapy 2.
Contraindications:
Common side effects:
- Nausea (30-40% of patients, usually mild-moderate and diminishes over time) 2
- Insomnia and abnormal dreams 2
- Headache
The titration schedule specifically addresses nausea—titrated dosing produces lower nausea rates than non-titrated approaches 4.
Clinical Pearls
Varenicline is more effective than:
Combination therapy: While varenicline monotherapy is highly effective, combining it with nicotine patch may provide additional benefit in some patients, though evidence is mixed 5, 3.
Re-treatment: Patients who relapse after initial treatment can be re-treated with varenicline once factors contributing to the failed attempt are addressed 1.